RHYTHM PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.43 USD | +4.20% |
|
+4.33% | -9.88% |
Chart calendar Rhythm Pharmaceuticals, Inc.
7823cf571ba1dd77.L8RlUH2kmJIaSO9mDqUx_EOqJvCiJbhUHnQpldFoRbU.S65dNyX80-ZYcbUISeZ7twHhH5fvSuAicQF44LsQEdFC9hJjJcPp0y4B2w~a9c720c900c102a99e9f94ad6f1ff291
Upcoming events on Rhythm Pharmaceuticals, Inc.
Past events on Rhythm Pharmaceuticals, Inc.
| 09/04/2024 11:45 pm | Needham Healthcare Conference |
| 14/03/2024 05:00 pm | Barclays Global Healthcare Conference |
| 06/03/2024 01:20 am | TD Cowen Health Care Conference |
| 22/02/2024 06:30 pm | Q4 2023 Earnings Call |
| 22/02/2024 05:30 pm | Q4 2023 Earnings Release |
| 08/02/2024 12:00 am | Guggenheim Healthcare Talks Biotechnology Conference |
| 06/12/2023 06:30 pm | R&D Day |
| 16/11/2023 12:55 am | Stifel Healthcare Conference - Fireside Chat |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Call |
| 07/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 18/10/2023 05:30 pm | The Obesity Society Meeting |
| 21/09/2023 | European Society for Paediatric Endocrinology Meeting |
| 12/09/2023 06:30 pm | H.C. Wainwright Global Investment Conference |
| 11/09/2023 10:25 pm | Morgan Stanley Global Healthcare Conference |
| 07/09/2023 07:00 pm | Wells Fargo Healthcare Conference |
| 09/08/2023 06:30 pm | Canaccord Genuity Growth Conference |
| 01/08/2023 05:30 pm | Q2 2023 Earnings Call |
| 01/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 21/06/2023 11:30 pm | Annual General Meeting |
| 14/06/2023 11:10 pm | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,22 - | 3,15 3,02 4.3% | 23,6 21,4 10.58% | 77,4 78,8 -1.74% | 132 |
|
EBITDA Million USD | Released Forecast Spread | -145 -147 1.08% | -136 -144 5.71% | -169 -161 -5.22% | -177 -177 -0.19% | -183 -179 -1.88% | -263 |
|
EBIT Million USD | Released Forecast Spread | -146 -151 3.33% | -137 -140 2.14% | -170 -167 -2.06% | -179 -182 1.75% | -184 -185 0.32% | -280 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -141 -146 3.63% | -134 -136 1.14% | -69,6 -66,6 -4.44% | -181 -184 1.68% | -184 -185 0.28% | -282 |
|
Net income Million USD | Released Forecast Spread | -141 -146 3.55% | -134 -135 0.49% | -69,6 -72,9 4.46% | -181 -184 1.5% | -185 -185 -0.05% | -280 |
|
EPS USD | Released Forecast Spread | -3,86 -3,93 1.71% | -3,04 -3,04 -0.09% | -1,40 -1,46 4.24% | -3,47 -3,55 2.12% | -3,20 -3,21 0.43% | -4,17 |
| Announcement Date | 02/03/20 | 01/03/21 | 01/03/22 | 01/03/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,82 1,70 6.75% | 1,50 2,30 -34.87% | 9,07 2,57 253.38% | 4,28 4,76 -10.02% | 8,79 7,16 22.84% | 11,5 12,1 -5.36% | 19,2 15,0 27.9% | 22,5 22,2 1.47% | 24,2 25,4 -4.51% | 26,9 | 31,2 | 35,5 | 39,2 | 45,6 |
|
EBIT Million USD | Released Forecast Spread | -51,0 -47,9 -6.56% | -52,7 -52,1 -1.05% | -45,1 -52,8 14.54% | -39,3 -51,4 23.65% | -42,1 -45,7 7.89% | -52,5 -41,3 -27.28% | -46,6 -44,1 -5.63% | -44,0 -43,9 -0.2% | -41,3 -42,3 2.45% | -126 | -50,7 | -53,6 | -52,1 | -34,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -50,9 -48,5 -4.79% | -52,8 -51,8 -1.91% | -45,0 -52,8 14.73% | -40,9 -50,8 19.49% | -42,5 -46,8 9.28% | -52,2 -40,4 -29.08% | -46,7 -47,3 1.16% | -43,8 -43,8 -0.03% | -41,4 -43,3 4.42% | -113 | -54,6 | -60,2 | -60,3 | |
|
Net income Million USD | Released Forecast Spread | -42,9 -46,2 7.14% | -52,8 -51,8 -1.89% | -45,0 -52,9 14.9% | -40,9 -51,6 20.81% | -42,5 -45,8 7.32% | -52,2 -40,8 -27.92% | -46,7 -44,1 -5.91% | -44,2 -44,7 1.24% | -41,6 -42,2 1.37% | -123 | -51,6 | -54,7 | -52,7 | -34,3 |
|
EPS USD | Released Forecast Spread | -0,85 -0,91 6.59% | -1,05 -1,01 -3.83% | -0,89 -0,95 6.17% | -0,79 -1,01 21.56% | -0,74 -0,82 9.34% | -0,92 -0,71 -30.37% | -0,82 -0,78 -4.63% | -0,76 -0,76 -0.16% | -0,70 -0,71 1.75% | -2,02 | -0,72 | -0,81 | -0,69 | -0,53 |
| Announcement Date | 01/03/22 | 03/05/22 | 02/08/22 | 08/11/22 | 01/03/23 | 02/05/23 | 01/08/23 | 07/11/23 | 22/02/24 | - | - | - | - | - |
| Today 03:30 pm | AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| Today 04:00 pm | REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 04:30 pm | AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| Today 08:30 pm | GENMAB A/S: Q1 2024 Earnings Release |
| Today 01:31 am | ASCENDIS PHARMA A/S: Q1 2024 Earnings Release |
| 06/05/2024 | FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release |
| 06/05/2024 | MERUS N.V.: Q1 2024 Earnings Release (Projected) |
| 06/05/2024 | VAXCYTE, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Rhythm Pharmaceuticals, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RYTM Stock
- Calendar Rhythm Pharmaceuticals, Inc.
